Chargement en cours...

CSF biomarkers for Alzheimer disease — approaching consensus

A European working group has provided a new set of recommendations for the use of cerebrospinal fluid (CSF) biomarkers in the diagnostic evaluation of Alzheimer disease and mild cognitive impairment. These recommendations represent an important step towards the implementation of CSF biomarker tests...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nat Rev Neurol
Auteurs principaux: Galasko, Douglas R., Shaw, Leslie M.
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5912691/
https://ncbi.nlm.nih.gov/pubmed/28155892
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrneurol.2017.11
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!